DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
MAPK signaling pathway	R-HSA-9652817	map04010	norcyclobenzaprine	9918	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	norcyclobenzaprine	9918	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	norcyclobenzaprine	9918	drug-path
Autoimmune thyroid disease	R-HSA-1643685	map05320	norcyclobenzaprine	9918	drug-path
Olfactory transduction	R-HSA-9751605	map04740	norcyclobenzaprine	9918	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	norcyclobenzaprine	9918	drug-path
Asthma	R-HSA-444620	map05310	norcyclobenzaprine	9918	drug-path
Endometrial cancer	R-HSA-2077421	map05213	norcyclobenzaprine	9918	drug-path
Allograft rejection	R-HSA-9679028	map05330	norcyclobenzaprine	9918	drug-path
Small cell lung cancer	R-HSA-5619066	map05222	norcyclobenzaprine	9918	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	norcyclobenzaprine	9918	drug-path
Alzheimer's disease	R-HSA-1643685	0	vorinostat	5311	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	vorinostat	5311	drug-path
Taste transduction	R-HSA-162582	map04742	vorinostat	5311	drug-path
Olfactory transduction	R-HSA-9751605	map04740	vorinostat	5311	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	vorinostat	5311	drug-path
Chemokine signaling pathway	R-HSA-168638	map04062	vorinostat	5311	drug-path
Parkinson's disease	R-HSA-1643685	0	vorinostat	5311	drug-path
Cardiac muscle contraction	R-HSA-397014	map04260	vorinostat	5311	drug-path
Cytokine-cytokine receptor interaction	R-HSA-6788467	map04060	vorinostat	5311	drug-path